The impact of highly active antiretroviral therapy on high-risk behaviour of HIV-infected patients in sub-Saharan Africa

被引:12
|
作者
Kaye, Dan Kabonge [1 ]
Kakaire, Othman [1 ]
Osinde, Michael Odongo [2 ]
Lule, John Chrysotom [1 ]
Kakande, Nelson [3 ]
机构
[1] Makerere Univ, Coll Hlth Sci, Dept Obstet & Gynecol, Sch Med, Kampala, Uganda
[2] Jinja Reg Hosp, Dept Obstet & Gynecol, Jinja, Uganda
[3] Joint Clin Res Ctr, Clin Operat & Hlth Serv Res Program, Kampala, Uganda
来源
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES | 2013年 / 7卷 / 06期
关键词
HIV infection; HIV care; high risk behavior; sub-Saharan Africa; SAFER SEXUAL-BEHAVIORS; REPRODUCTIVE INTENTIONS; DEVELOPING-COUNTRIES; POSITIVE WOMEN; TRANSMISSION; DISCLOSURE; SEROSTATUS; HAART; RATES; CARE;
D O I
10.3855/jidc.2644
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: High-risk sexual behaviors such as multiple sexual partners, inconsistent condom use, acquisition of sexually transmitted infection (STIs), and non-use of contraceptives persist in HIV patients undergoing care. We conducted a systematic review of studies conducted in the era of increased access to HAART (2000-2010) to assess whether wide-scale use of HAART was associated with high-risk behavior among HAART-using patients. Methodology: We conducted a comprehensive search of databases (AIDSLINE, National Library of Medicine, MEDLINE, PubMed, CINHAL and EMBASE) from January 2002 to January 2010, reviewed conference proceedings and journals, and contacted the researchers involved. We analyzed the association of high-risk behaviors (non-disclosure of sero-status to sexual partners, inconsistent condom use, unprotected sexual intercourse, multiple sexual partners, non-use of contraceptives and acquisition of STIs) with using HAART. Information from eligible studies was abstracted using a standardized checklist. Fourteen English-language studies met the selection criteria of having high-risk behavior as an outcome in patients using HAART in sub-Saharan Africa. Results: Of the 92 eligible articles screened, 14 met the criteria for inclusion as primary articles, 10 showed that HAART is not associated with increased high-risk behavior, two showed increase in acquisition of STIs among HAART-using patients, (which was inconsistent with other measures of high-risk behavior), and two studies showed short-term increase in high-risk behavior. Conclusions: Persistence of high-risk behavior in HAART-using patients suggests that more effort needs to be incorporated in HIV care to reduce such behavior to reduce HIV transmission to uninfected populations.
引用
收藏
页码:436 / 447
页数:12
相关论文
共 50 条
  • [21] Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa (vol 8, pg 477, 2008)
    Sutcliffe, C. G.
    van Dijk, J. H.
    Bolton, C.
    Persaud, D.
    Moss, W. J.
    LANCET INFECTIOUS DISEASES, 2009, 9 (12): : 736 - 736
  • [22] The potential impact of antiretroviral therapy on fertility in sub-Saharan Africa
    Kaida A.
    Andia I.
    Maier M.
    Strathdee S.A.
    Bangsberg D.R.
    Spiegel J.
    Bastos F.I.
    Gray G.
    Hogg R.
    Current HIV/AIDS Reports, 2006, 3 (4) : 187 - 194
  • [23] Pruritus in HIV-infected patients in the era of highly active antiretroviral therapy
    Blanes, Mar
    Belinchon, Isabel
    Betlloch, Isabel
    Portilla, Joaquin
    Reus, Sergio
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB119 - AB119
  • [24] Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa
    Stephen B. Asiimwe
    Michael Kanyesigye
    Bosco Bwana
    Samson Okello
    Winnie Muyindike
    BMC Infectious Diseases, 16
  • [25] Homocysteinaemia in HIV-infected patients treated with highly active antiretroviral therapy
    Bernasconi, E
    Uhr, M
    Magenta, L
    Ranno, A
    Telenti, A
    AIDS, 2001, 15 (08) : 1081 - 1082
  • [26] Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy
    Foulon, G
    Wislez, M
    Naccache, JM
    Blanc, FX
    Rabbat, A
    Israël-Biet, D
    Valeyre, D
    Mayaud, C
    Cadranel, J
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) : 418 - 425
  • [27] Hospitalized HIV-Infected Patients in the Era of Highly Active Antiretroviral Therapy
    Metsch, Lisa R.
    Bell, Christine
    Pereyra, Margaret
    Cardenas, Gabriel
    Sullivan, Tanisha
    Rodriguez, Allan
    Gooden, Lauren
    Khoury, Nayla
    Kuper, Tamy
    Brewer, Toye
    del Rio, Carlos
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2009, 99 (06) : 1045 - 1049
  • [28] Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients
    Sendi, PP
    Bucher, HC
    Harr, T
    Craig, BA
    Schwietert, M
    Pfluger, D
    Gafni, A
    Battegay, M
    AIDS, 1999, 13 (09) : 1115 - 1122
  • [29] Cardiovascular disease in HIV-infected patients on highly active antiretroviral therapy
    Jericó, C
    Knobel, H
    Carmona, A
    Sorli, ML
    López-Colomés, JL
    Pedro-Botet, J
    MEDICINA CLINICA, 2004, 122 (08): : 298 - 300
  • [30] Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients
    Barbaro, G
    Klatt, EC
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (18) : 1475 - 1481